Massachusetts Financial Services
PETX

Massachusetts Financial Services’s Aratana Therapeutics, Inc. PETX Stock Holding History

Massachusetts Financial Services’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,590,967
Closed -$5.73M – 884
2019
Q1 		$5.73M Buy
1,590,967
+91,800
+6% +$398K ﹤0.01% 656
2018
Q4 		$9.19M Buy
1,499,167
+7,971
+0.5% +$48.6K ﹤0.01% 609
2018
Q3 		$8.71M Buy
1,491,196
+114,998
+8% +$575K ﹤0.01% 644
2018
Q2 		$5.85M Buy
1,376,198
+365,750
+36% +$1.84M ﹤0.01% 669
2018
Q1 		$4.46M Buy
1,010,448
+10,404
+1% +$46.4K ﹤0.01% 672
2017
Q4 		$5.26M Buy
1,000,044
+9,341
+0.9% +$57.1K ﹤0.01% 662
2017
Q3 		$6.07M Buy
990,703
+6,009
+0.6% +$38K ﹤0.01% 655
2017
Q2 		$7.12M Sell
984,694
-205
-0% -$1.26K ﹤0.01% 650
2017
Q1 		$5.22M Sell
984,899
-1,429
-0.1% -$9.65K ﹤0.01% 650
2016
Q4 		$7.08M Sell
986,328
-2,444
-0.2% -$19.8K ﹤0.01% 633
2016
Q3 		$9.26M Buy
988,772
+16,837
+2% +$140K ﹤0.01% 588
2016
Q2 		$6.14M Buy
971,935
+47,102
+5% +$303K ﹤0.01% 620
2016
Q1 		$5.11M Buy
924,833
+11,705
+1% +$44K ﹤0.01% 640
2015
Q4 		$5.09M Sell
913,128
-6,495
-0.7% -$42.9K ﹤0.01% 651
2015
Q3 		$7.78M Sell
919,623
-60,864
-6% -$1.03M ﹤0.01% 624
2015
Q2 		$14.8M Sell
980,487
-14,562
-1% -$210K 0.01% 568
2015
Q1 		$15.9M Sell
995,049
-115,263
-10% -$2.05M 0.01% 570
2014
Q4 		$19.8M Sell
1,110,312
-136,091
-11% -$1.7M 0.01% 530
2014
Q3 		$12.5M Buy
1,246,403
+268,284
+27% +$3.25M 0.01% 611
2014
Q2 		$15.3M Buy
978,119
+149,919
+18% +$2.12M 0.01% 577
2014
Q1 		$15.4M Buy
+828,200
New +$16.6M 0.01% 538

Other funds holding PETX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WIC
Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.96% 1-Year Est. Return

Massachusetts Financial Services's PETX Position: Q2 2019 in Review

Massachusetts Financial Services sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2019, closing a stake of 1,590,967 shares — an estimated $5.73M sold.

Massachusetts Financial Services first reported a position in PETX in Q1 2014 and held it in 21 quarters. The position peaked at $19.8M in Q4 2014. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.

  • Massachusetts Financial Services reported no remaining Aratana Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Massachusetts Financial Services sold 1,590,967 Aratana Therapeutics, Inc. shares in Q2 2019, an estimated $5.73M.
  • Massachusetts Financial Services first reported a position in Aratana Therapeutics, Inc. in Q1 2014 and held it in 21 quarters.
  • Massachusetts Financial Services's Aratana Therapeutics, Inc. position peaked at $19.8M in Q4 2014.
  • 103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.

Based on Massachusetts Financial Services's 13F filing for Q2 2019, filed 14 Aug 2019.